As the crisp autumn air fills Qingdao with the scent of osmanthus, the 2025 China International Pharmaceutical Machinery Exposition (CIPM) – Autumn Edition is set to take place from October 16–18. Recognized as a leading event in the pharmaceutical equipment sector, the expo will empower the industry through cutting-edge technology, foster new growth opportunities on a global scale, highlight the latest innovations, and bring together industry leaders to tackle the challenges of this transformative period.

Fueled by strong policy support, technological innovation, and investment momentum, China’s era of innovative pharmaceuticals is accelerating. Morimatsu is committed to addressing pharmaceutical companies’ needs for cost reduction, efficiency improvement, and collaborative innovation amid major industry transformations. By anticipating trends and seizing opportunities in the industrialization of next-generation innovative drugs, Morimatsu leverages both policy guidance and market dynamics to drive breakthrough growth in China’s innovative drug sector.

Morimatsu & MoriSora Booth

At this year’s exhibition, MoriSora Technology, a subsidiary of Morimatsu LifeSciences specializing in lyophilization equipment, will showcase its advanced lyophilization system solutions at Booth N5-57.

MoriSora Technology, a subsidiary of Morimatsu LifeSciences specializing in lyophilization equipment, provides comprehensive and systematic solutions for life and health science-related enterprises, laboratories, and research centers. Its applications span:

1.Pharmaceuticals and Biotechnology

Vacuum lyophilization is a critical process in the production of biologics and pharmaceutical products. The performance and reliability of lyophilizers directly affect drug quality and patient safety, serving as a key safeguard in manufacturing.

2.Diagnostics and Healthcare

In diagnostic reagents, lyophilization preserves reagent activity, extends shelf life, and improves stability during transportation.

In the nutritional supplements sector, lyophilizers prevent nutrient degradation caused by conventional high-temperature drying, and ensure high-quality, high-potency products for consumers.

3.Skincare and Medical Aesthetics

In skincare and medical aesthetics, lyophilizers enhance product stability and shelf life while reducing the need for additives. They maintain the efficacy of active ingredients in treatments and care products, including skin repair and anti-aging formulations.

4.Premium Food Processing

Lyophilization serves as a key technique in modern food processing, preserving the original shape, color, and nutritional value of food and enabling long-term dry storage.

Built on the core concept of integrating functional units, MoriSora's lyophilization system combines lyophilizers, in-feed and out-feed systems, Grade A environmental barrier systems, and filling systems into a seamless solution. The system delivers three major technological advantages: flexible adaptability, high efficiency with energy savings, and intelligent control. It also offers dual support through both equipment and services, ensuring comprehensive performance and reliability.

Through strategic dialogue and collaboration, Morimatsu helps companies in the pharmaceutical equipment sector identify needs, capture opportunities, and plan for the future. At the exhibition, MoriSora presented its lyophilization system solution and supported the advancement of the pharmaceutical industry.

We cordially invite you to visit our booth
and look forward to partnering with you
to write a new chapter in collaborative success

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.